期刊文献+

水溶性富勒烯作为药物载体在生物医学上的应用 被引量:2

Application of Water-soluble Fullerene as Drug Carriers in Biomedicine
下载PDF
导出
摘要 将改性后的功能型富勒烯用作药物载体已成为一个研究热点。越来越多的研究表明功能型富勒烯在药物载体领域具有光明的应用前景。本文概述了几种常见的水溶性富勒烯和功能型富勒烯药物载体,并分别对其研究现状进行了介绍,对多功能型富勒烯药物载体研究的前景进行了展望,旨在促进富勒烯作为药物载体在生物医学领域的深层次发展。 Using modified functional fullerene as drug carrier has been a research hotspot. More and more studies indicated that the functional fullerenes have bright application prospects in the field of drug carriers. In this paper,several common water-soluble fullerenes and functional fullerenes were summarized,and their current research statuses were introduced respectively. The prospect of the research on multi-functional fullerene drug carrier was prospected at last,in order to promote the deeper development of the fullerenes as drug carrier in the biomedical field.
作者 熊大艳 刘万云 XIONG Da - yan, LIU Wan - yun(Key Laboratory of Jiangxi University for Applied Chemistry and Chemical Biology, Yichun University, Yichun 336000, China)
出处 《宜春学院学报》 2018年第9期12-16,共5页 Journal of Yichun University
基金 国家自然科学基金项目(NO:21764016) 江西省自然科学基金项目(NO:20161BAB215197) 江西省教育厅科技项目(GJJ151031)
关键词 富勒烯 药物载体 生物医学 水溶性 多功能 Fullerene drug carrier biomedicine water solubility Multi - function
  • 相关文献

参考文献3

二级参考文献33

  • 1刘爱红,孙康宁,李爱民,魏源,孙昌.CNTs/HAp复合材料及其动物离体组织热效应研究[J].功能材料,2006,37(8):1322-1324. 被引量:5
  • 2张龙彬,朱光明,许硕贵,王金花,秦瑞丰.辐射交联聚己内酯的酶降解动力学研究[J].辐射研究与辐射工艺学报,2006,24(5):275-278. 被引量:2
  • 3谢劲松,魏先文.卤化富勒烯研究进展[J].化学进展,2007,19(2):313-324. 被引量:9
  • 4尹峰,赵紫霞,吴宝艳,王新胜,王艳艳,陈强.基于多壁碳纳米管和聚丙烯胺层层自组装的葡萄糖生物传感器[J].分析化学,2007,35(7):1021-1024. 被引量:23
  • 5Anton W J, Stephen R W, David I. Biological applications of fullerenes. Bioorg Med Chem, 1996, 4:767--779.
  • 6Tokuyama H, Yamago S, Nakamura E, et al. Photoinduced biochemical activity of fullerene carboxylic acid. J Am Chem Soc, 1993, 115: 7918--7919.
  • 7Yang X L, Fan C H, Zhu H S. Photo-induced cytotoxicity of malonic acid [C-60]fullerene derivatives and its mechanism. Toxicol In Vitro, 2002, 16:41-46.
  • 8Sijbesma R, Srdanov G, Wudl F, et al. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J Am Chem Soc, 1993, 115: 6510--6512.
  • 9Friedman S H, Ganapathi P S, Rubin Y, et al. Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in bydrophobic desolvation. J Med Chem, 1998, 41:2424--2429.
  • 10Nakamura E, Tokuyama H, Yamago S, et al. Biological activity of water-soluble fullerenes. Structural dependence of DNA cleavage, cytotoxicity, and enzyme inhibitory activities including HIV-protease inhibition. Bull Chem Soc Jpn, 1996, 69:2143--2151.

共引文献32

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部